Evidence map›Paper›PMID 41252556›Full record

ArticleNeuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition2026

Apoe genotype knowledge and its impact on cognitive beliefs and performance.

Sarah J Barber, Meenakshi Menon, Katherine J Shoemaker, Mara Mather, Jessica B Langbaum, Jason Karlawish

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sarah J BarberDepartment of Psychology, Georgia State University, Atlanta, GA, USA.
Meenakshi MenonDepartment of Psychology, Georgia State University, Atlanta, GA, USA.
Katherine J ShoemakerDepartment of Psychology, Georgia State University, Atlanta, GA, USA.
Mara MatherLeonard Davis School of Gerontology, University of Southern California, Los Angeles, CA, USA.
Jessica B LangbaumBanner Alzheimer's Institute, Phoenix, AZ, USA.
Jason KarlawishDepartment of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Funding

Alzheimer's Prevention Initiative APOE4 TrialUF1AG046150 · NIA · BANNER ALZHEIMER'S INSTITUTE · PI REIMAN, ERIC MICHAEL, TARIOT, PIERRE N. · 2013 to 2013
$33.3M
Research Education ComponentP30AG072980 · NIA · BANNER HEALTH · PI HEATHER Allyson BIMONTE-NELSON · 2021 to 2026
$24.9M
NIA NIH HHS P30 AG072980NIA NIH HHS UF1 AG046150
6 · The paper itself

Abstract

As genetic testing for Alzheimer's disease (AD) risk becomes increasingly accessible, it is important to understand how individuals respond to knowledge of their genetic risk. In this study, we examined whether awareness of being an APOE ɛ4 carrier, a genetic risk factor for late-onset AD dementia, adversely affects subjective and objective cognition. Participants were 195 cognitively unimpaired older adults (aged 63-79,

Indexed as

Apolipoprotein E4CognitionHealth Knowledge, Attitudes, PracticeAgedAlzheimer DiseaseAttentionFemaleGenotypeHeterozygoteHumansMaleMemory, EpisodicMemory, Short-TermMiddle AgedNeuropsychological TestsApolipoprotein E4Apoe genotypegenetic testingmemory control beliefsstereotype threatsubjective cognition

Identifiers

PMID41252556
PMCPMC13693370

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.